Boeing has shown clear signs of operational recovery over the last year, with free cash flow turning positive after a multi-year deficit and production rates stabilizing across its commercial aircraft lines. In 2025 the company delivered more jets than the prior year, bolstering its backlog to a multi-year high. Defense segment margins have also shifted into positive territory, driven by higher F-15E and rotorcraft deliveries. Yet investors remain cautious: consensus earnings-per-share estimates have been revised downward three times in the past six months, reflecting ongoing certification delays on key narrow-body variants and elevated unit costs associated with ramping up production. The shares have rallied roughly 45% over the past 12 months, but market participants warn that any disappointment in cost control or delivery targets could trigger profit-taking.

According to data from the U.S. Commerce Department’s International Trade Administration, Boeing accounted for the majority of a $244 billion surge in U.S. companies’ foreign government procurement contracts in 2025. Jetliner orders jumped to 1,075 net units—its sixth-best year on record and the first time in seven years it outpaced Airbus on net orders—bringing approximately $206 billion of U.S. export content. The deals are expected to support some 844,000 American jobs across manufacturing, supply-chain services and aftermarket operations. This influx of export business has provided a counterweight to domestic defense competition and underscores Boeing’s pivotal role in Washington’s trade diplomacy.

With Boeing set to report fourth-quarter results on January 27, Wall Street strategists remain divided. Bulls highlight production momentum—deliveries rose mid-single digits year-over-year in Q4—and growing defense sales as evidence the turnaround is sustainable. Bearish voices caution that margin expansion will be limited if certification hurdles on the 737 MAX and 787 persist, and that negative EPS revisions leave little room for upside surprises. Despite a nearly 41% share appreciation in 2025, several leading equity analysts assign a “Hold” rating, pointing to valuation stretching and the risk of short-term volatility should the company miss on either deliveries or cost guidance.